---
layout: post
title: "Quality Management Maturity Program for Drug Manufacturing Establishments; Establishment of a Public Docket; Request for Comments"
date: 2026-02-05 18:56:50 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-20015
original_published: 2023-09-15 00:00:00 +0000
significance: 8.00
---

# Quality Management Maturity Program for Drug Manufacturing Establishments; Establishment of a Public Docket; Request for Comments

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 15, 2023 00:00 UTC
**Document Number:** 2023-20015

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the establishment of a docket to solicit comments that will assist the Agency in developing a Quality Management Maturity (QMM) program for establishments manufacturing human drugs, including biological products, regulated by the Center for Drug Evaluation and Research (CDER).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/15/2023-20015/quality-management-maturity-program-for-drug-manufacturing-establishments-establishment-of-a-public)
- API: https://www.federalregister.gov/api/v1/documents/2023-20015

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
